WCWei-Shone Chen

Wei-Shone Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei-Shone Chen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Jacqueline Ming Liu

    Cancer Research Center, National Health Research Institutes, Taipei, Taiwan, Republic of China

    1 shared publication
  • Jacqueline Whang-Peng

    Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China

    1 shared publication
  • Jeou Yuan Chen

    Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China

    1 shared publication
  • Kuang Liang King

    Division of General Surgery, Department of Surgery, Veterans General Hospital, Taipei, Taiwan, Republic of China

    1 shared publication
  • Wen Chang Lin

    Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China

    1 shared publication
  • Wen Kuang Yang

    Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases

    by Wei-Shone Chen, Jeou Yuan Chen, Jacqueline Ming Liu, Wen Chang Lin, Kuang Liang King, Jacqueline Whang-Peng, Wen Kuang Yang

    Microsatellite instability (MSI) is intrinsic to most colorectal carcinomas (CRC) from patients with hereditary non‐polyposis colorectal cancer (HNPCC), reflecting germline mutations in the mismatch‐repair (MMR) genes. Its occurrence and chronological sequence of development in sporadic CRC appears less well defined. To explore the time sequence in acquisition of MSI, and the role it plays during tumor progression in sporadic CRC, we compared the incidence of MSI in tissue samples from 40 Dukes'‐B and 30 Dukes'‐D CRC patients with liver metastases, at 4 different microsatellite loci, representing sites on the APC, DCC and p53 genes respectively as well as the D2S123 site. Among the 30 patients with hepatic metastases, MSI was found in 9 (30%) of the primary, and 13 (43.3%) of the metastatic tumors. In comparison, among the 40 Dukes'‐B CRC, MSI was found in only 8 cases (20%). CRC with MSI were more frequently located in the right colon, less frequently on the left side, and seldom in the rectum. Tumor ploidy analysis shows that 46.2% of Dukes'‐D primary tumors with MSI are diploid (χ2 = 4.46, p = 0.035). With a mean follow‐up time of 4.2 years for the Dukes'‐B CRC, there were no recurrences in the 8 patients with MSI, whilst 6 (18.8%) relapses occurred amongst the 32 patients without MSI, average time to recurrence being 15 months. In Dukes'‐D CRC, mean survival time for patients with MSI was 37 months (95% CI, 24 to 51 months), for those without MSI 26 months (95% CI, 18 to 35 months), although this was not statistically significant. Our data suggest that tumor progression may involve increased genetic instability. Int. J. Cancer 74:470–474, 1997.